Cardinal Health Issues Correction for Presource Packs with BD Alaris Sets
Cardinal Health has issued a device correction for Presource Kits containing certain BD Alaris Pump Infusion Sets following a recall of the infusion sets. The affected kits involve components that can cause unpredictable pump behavior, such as under-infusion, over-infusion, or failure to infuse, which may lead to severe adverse events or death in vulnerable populations.
The FDA has classified this action as a Class I recall. The manufacturer advises customers to locate and quarantine affected kits, alert clinicians, and affix a warning label instructing staff to remove and discard the recalled infusion sets prior to using the kits.
Key points
- Cardinal Health is correcting Presource Kits containing recalled BD Alaris Pump Infusion Sets.
- Defective infusion sets can cause unpredictable pump behavior including under-infusion, over-infusion, or failure to infuse.
- The FDA has classified this action as a Class I recall, noting risks of severe adverse events especially in high-risk patients.
- Facilities are advised to quarantine affected kits and affix warning labels to remove and discard the recalled components.
What it means for you
Clinicians and pharmacists should be aware of potential malfunctions in infusion sets contained within convenience kits that could lead to severe adverse events in vulnerable patients. Healthcare facilities should check for affected inventory and follow manufacturer instructions to quarantine kits and remove recalled components. Since this is an international regulatory alert, clinicians in Pakistan should check with the Drug Regulatory Authority of Pakistan (DRAP) for any local availability and guidance regarding these affected products.
Convenience Kit Correction: Cardinal Health Issues Correction for Presource Packs Containing BD Alaris Pump Infusion Sets
Summarised automatically from the official announcement. For educational purposes only — check the original source before making clinical decisions.
